Atlas Trials

99mTc Sestamibi Scans In Thyroglobulin Positive Scan Negative Differentiated Thyroid Cancer (DTC) Patients

Clinical trial NCT03065218 · TERMINATED

Trial details

NCT number
NCT03065218
Sponsor
Medstar Health Research Institute
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Thyroid Cancer
Start date
2016-10-01
Primary completion
2021-02-15
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.